Yini i-Idecabtagene Vicleucel: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Idecabtagene vicleucel yindlela yokwelapha umdlavuza eshintsha umhlaba wonke esebenzisa amaseli akho omzimba ukulwa ne-multiple myeloma. Le ndlela yokwelapha entsha, eyaziwa nangokuthi i-ide-cel noma ngegama layo lomkhiqizo elithi Abecma, imelela intuthuko enkulu ekunakekelweni komdlavuza okwenzelwe umuntu ngamunye.

Cabanga ngayo njengokunikeza amasosha omzimba wakho ukuthuthukiswa okunamandla. Ama-T-cells akho (amasosha omzimba wakho) ayaqoqwa, ashintshwe ngofuzo elabhorethri ukuze akwazi kangcono ukuqaphela nokuhlasela amaseli omdlavuza, bese efakwa emzimbeni wakho ukuze alwe nesifo ngaphakathi.

Yini i-Idecabtagene Vicleucel?

I-Idecabtagene vicleucel wuhlobo lwe-CAR-T cell therapy olwenzelwe ngqo i-multiple myeloma. I-CAR-T imelela ukuthi “Chimeric Antigen Receptor T-cell” therapy, okungase kuzwakale kuyinkimbinkimbi, kodwa umqondo muhle kakhulu.

Ama-T-cells akho aqoqwa ngenqubo efana nokunikela ngegazi. Lawa maseli athunyelwa elabhorethri ekhethekile lapho ososayensi bewashintsha ngofuzo ukuze akhiqize izamukeli ezikhethekile ezibizwa ngokuthi ama-CAR. Lezi zamukeli zenza njengama-missile aqondisiwe, ahlelwe ukuthola nokubhubhisa amaseli omdlavuza aneprotein ethile ebizwa nge-BCMA ebusweni bawo.

Lapho ama-T-cells akho aguquliwe eselungele, afakwa emgudwini wakho wegazi nge-IV. Lawa maseli omzimba anamandla amakhulu abese ezulazula emzimbeni wakho wonke, efuna futhi eqeda amaseli e-multiple myeloma ngokunemba okukhulu.

Isetshenziselwani i-Idecabtagene Vicleucel?

I-Idecabtagene vicleucel ivunyelwe ngokuqondile kubantu abadala abane-multiple myeloma abaye bazama okungenani ukwelashwa okune okwedlule ngaphandle kwempumelelo. Lokhu kuhlanganisa iziguli ezinomdlavuza obuyile ngemva kokwelashwa noma ezingazange zisabele ekwelashweni okujwayelekile.

I-Multiple myeloma ngumdlavuza othinta amaseli e-plasma emnkantsheni wakho. Lawa ngamaseli abhekele ukukhiqiza ama-antibody okulwa nezifo. Lapho eba nomdlavuza, azala ngaphandle kokulawulwa futhi axoshe amaseli egazi anempilo.

Udokotela wakho angase ancome lokhu kwelashwa uma usuvele uzamile inhlanganisela eminingana yokwelashwa okujwayelekile kwe-multiple myeloma. Lokhu kuvame ukuhlanganisa imithi efana ne-lenalidomide, pomalidomide, bortezomib, carfilzomib, daratumumab, noma ukufakelwa kwamaseli esiqu, futhi umdlavuza wakho ubuyile noma awuphenduli ngendlela efanele.

Isebenza Kanjani Idecabtagene Vicleucel?

I-Idecabtagene vicleucel isebenza ngokuguqula amasosha akho omzimba abe yiqembu elisebenza kahle lokulwa nomdlavuza. Lokhu kwelashwa kuthathwa njengokunamandla kakhulu emhlabeni wokwelashwa komdlavuza, okumele enye yezindlela ezithuthukiswe kakhulu esinazo.

Inqubo iqala lapho ama-T-cell akho eqoqwa futhi enziwa ngofuzo ukukhiqiza ama-receptor akhethekile angakwazi ukuqaphela iphrotheni ebizwa nge-BCMA. Amaseli amaningi e-multiple myeloma anama-BCMA amaningi ebusweni bawo, okwenza abe yizindawo eziqondiswe kahle kula maseli omzimba aguquliwe.

Uma efakwe emzimbeni wakho, lawa ma-T-cell athuthukisiwe azala futhi abe ibutho labalwi bomdlavuza. Aqapha emgudwini wakho wegazi nasemnkantsheni wamathambo, ethola futhi abhubhise amaseli e-myeloma ngendlela ehlelekile. Ubuhle bale ndlela ukuthi isebenzisa uhlelo lwakho lokuzivikela emzimbeni, ngamakhono angcono okuqondisa.

Okuthatha lokhu kwelashwa njengokuqinile ikhono lalo lokunikeza ukuvikelwa okuhlala isikhathi eside. Amanye ala ma-T-cell aguquliwe angahlala emzimbeni wakho izinyanga noma iminyaka, eqhubeka nokubheka noma yimaphi amaseli omdlavuza abuyayo.

Kufanele Ngiyithathe Kanjani Idecabtagene Vicleucel?

Idecabtagene vicleucel akuyona into oyithatha ekhaya njengepilisi noma umjovo. Lena inqubo eyinkimbinkimbi, enezinyathelo eziningi edinga ukuxhumana okucophelelayo phakathi kwakho nethimba lakho lezokwelapha esikhungweni esikhethekile somdlavuza.

Uhambo luqala nge-leukapheresis, inqubo lapho amaseli akho e-T eqoqwa ngenqubo efana nokunikela ngama-platelet. Uzoxhunywa emshinini ohlukanisa amaseli akho e-T egazini lakho, ngenkathi ubuyisela wonke amanye amangqamuzana egazi lakho kuwe. Lokhu kuvame ukuthatha amahora angu-3-6 futhi kuvame ukubekezeleleka kahle.

Ngenkathi amaseli akho ekhiqizwa e-laboratory (okuthatha amasonto angu-4), uzothola okubizwa ngokuthi i-lymphodepleting chemotherapy. Lokhu ngokuvamile kuhilela ukuthola i-fludarabine ne-cyclophosphamide nge-IV izinsuku ezintathu. Lesi sinyathelo sisiza ukusula isikhala ohlelweni lwakho lomzimba lokuzivikela ezifweni ukuze amaseli amasha e-CAR-T asebenze ngempumelelo.

Ngosuku lokufakwa, uzothola amaseli akho e-CAR-T aqanjelwe wena nge-IV, okufana nokuthola ukumpontshelwa igazi. Ukufakwa kwangempela kumangaza ngokushesha, ngokuvamile kuthatha ngaphansi kwehora elilodwa. Kodwa-ke, uzodinga ukuhlala eduze nesikhungo sokwelapha okungenani amasonto amane ngemva kwalokho ukuze uqashwe eduze.

Kufanele Ngiyithathe Isikhathi Esingakanani Idecabtagene Vicleucel?

Idecabtagene vicleucel ngokuvamile inikezwa njengokwelashwa okukodwa, hhayi ukwelashwa okuqhubekayo njenge-chemotherapy yendabuko. Uma amaseli akho e-T aguquliwe efakiwe, aklanyelwe ukuqhubeka esebenza emzimbeni wakho isikhathi eside.

Inqubo yokuqala yokwelashwa ihlanganisa amasonto angu-6-8 kusukela ekuqaleni kuya ekugcineni. Lokhu kuhlanganisa isikhathi sokuqoqwa kwamaseli, ukukhiqizwa, i-chemotherapy yokulungiselela, kanye nokufakwa ngokwako. Kodwa-ke, imiphumela yokwelashwa ingahlala isikhathi eside.

Ama-T-cell akho aguquliwe angase ahlale esebenza emzimbeni wakho izinyanga noma iminyaka ngemuva kokufakwa. Ezinye iziguli ziqhubeka nokuzuza kulokhu kwelashwa okukodwa isikhathi eside, yize izimpendulo zomuntu ngamunye zihluka kakhulu. Ithimba lakho lezokwelapha lizokuqapha ngokucophelela ngezivivinyo zegazi ezivamile kanye nezifundo zokuthwebula izithombe ukuze kulandelwe ukuthi ukwelashwa kusebenza kahle kangakanani.

Uma ukwelashwa kuyeka ukusebenza ngempumelelo ngokuhamba kwesikhathi, udokotela wakho angase axoxe ngezinketho ezithile, kodwa ukuphinda ukwelashwa kwe-CAR-T cell akuyona imikhuba ejwayelekile ngamaphrothokholi wamanje.

Yiziphi Imiphumela Eceleni ye-Idecabtagene Vicleucel?

Njengazo zonke izindlela zokwelapha umdlavuza ezinamandla, i-idecabtagene vicleucel ingabangela imiphumela emibi, eminye yayo engaba yingozi. Kodwa-ke, ithimba lakho lezokwelapha linolwazi olukhulu ekuphatheni le miphumela futhi lizokuqapha ngokucophelela kuyo yonke inkathi yakho yokwelashwa.

Ukuqonda okulindelekile kungakusiza ukuthi uzizwe ulungiseleleke kakhulu futhi ungakhathazeki ngale nqubo. Ake sihambe ngemiphumela emibi engaba khona, siqale ngaleyo ejwayelekile kakhulu bese sixoxa ngezinto ezingavamile kodwa ezingaba yingozi kakhulu.

Imiphumela Ejwayelekile Eceleni

Iziguli eziningi ziba nokukhathala okuthile nobuthakathaka emasontweni alandela ukwelashwa. Ungase futhi uqaphele izimpawu ezifana nesifo esifana nomkhuhlane, okuhlanganisa umkhuhlane, ama-chills, nobuhlungu bomzimba. Lokhu kwenzeka ngoba amasosha akho omzimba asebenza kanzima ukulwa nomdlavuza.

• Ukukhathala nobuthakathaka obungahlala amasonto amaningana
• Umkhuhlane nama-chills, ikakhulu ngesonto lokuqala ngemuva kokufakwa
• Isicanucanu nokuncipha kwesifiso sokudla
• Ikhanda elibuhlungu nesiyezi
• Ukubalwa kwegazi okuphansi, okungandisa ingozi yokutheleleka
• Ubuhlungu bemisipha namalunga
• Ukuqunjelwa noma ukuqunjelwa

Lezi zimpawu ngokuvamile ziyaqondakala ngokunakekelwa okusekelayo futhi zivame ukuthuthuka njengoba umzimba wakho uzivumela ekwelashweni. Ithimba lakho lezokwelapha lizohlinzeka ngemithi namasu okukusiza ukuthi uzizwe ukhululekile.

Imiphumela Emibi Engathi Sína

Kunemiphumela emibili engaba yingozi edinga ukunakekelwa ngokushesha kwezokwelapha: i-cytokine release syndrome (CRS) kanye nobuthi be-neurologic. Nakuba lokhu kuzwakala kusabisa, ithimba lakho lezokwelapha lilungele kahle ukukubona nokukwelapha ngokushesha.

I-Cytokine release syndrome yenzeka lapho amaseli akho e-T asebenzayo ekhipha izinto eziningi ezivuthayo ezibizwa ngokuthi ama-cytokines. Cabanga ngayo njengohlelo lwakho lomzimba lokuzivikela oluthokozela ngokweqile ukulwa nomdlavuza. Izimpawu zingabandakanya umkhuhlane ophezulu, umfutho wegazi ophansi, ubunzima bokuphefumula, nokuzizwa ungaphilile kahle.

Imiphumela emibi ye-Neurologic ingabandakanya ukudideka, ubunzima bokukhuluma, ukuthuthumela, noma ukuquleka. Lokhu kwenzeka ngoba amaseli omzimba okuzivikela asebenzayo ngezinye izikhathi angathinta uhlelo lwezinzwa. Izimpawu eziningi ze-neurologic zesikhashana futhi ziyanyamalala ngemithi efanele.

Imiphumela Emibi Engavamile Kodwa Ebalulekile

Ezinye iziguli zingase zithuthukise ukubala kwegazi okuphansi okweluliwe, okungandisa ingozi yokutheleleka, ukopha, noma i-anemia. Ezimweni ezingavamile, iziguli zingase zithuthukise imidlavaza yesibili ngemva kweminyaka yokwelashwa, nakuba le ngozi ibonakala iphansi kakhulu.

Kukhona futhi ithuba elincane lokuthuthukisa okubizwa ngokuthi i-tumor lysis syndrome, lapho amaseli omdlavuza ewohloka ngokushesha kangangokuthi akhiphe okuqukethwe kwawo egazini ngokushesha kunokuba izinso zakho zikwazi ukuwacubungula. Lokhu empeleni kuyisibonakaliso sokuthi ukwelashwa kuyasebenza, kodwa kudinga ukuqapha nokwelashwa okucophelelayo.

Ithimba lakho lezokwelapha lizoxoxa ngazo zonke lezi zinto nawe ngokuningiliziwe futhi liqinisekise ukuthi uqonda izimpawu zokuxwayisa okufanele uziqaphele. Khumbula, imiphumela emibi engathi sína iyalawuleka uma ibanjwe kusenesikhathi, yingakho ukuqapha eduze kubaluleke kangaka.

Ubani Ongafanele Athole Idecabtagene Vicleucel?

Akubona bonke abantu abanomdlavuza wamathambo abangaba ngabazongenela i-idecabtagene vicleucel. Ithimba lakho lezokwelapha lizohlola ngokucophelela impilo yakho yonke nomlando wakho wezokwelapha ukuze linqume ukuthi le mithi ikufanele yini.

Le mithi ayinconyelwe uma unezifo ezithile ezisebenzayo, ikakhulukazi izifo ezibangelwa amagciwane ezingathi sína njenge-HIV, i-hepatitis B, noma i-hepatitis C ezingalawuleki kahle. Uhlelo lwakho lomzimba lokuzivikela kufanele lube namandla ngokwanele ukubhekana nenqubo yokwelashwa, futhi izifo ezisebenzayo zingenza ukululama kube nzima.

Abantu abanezifo ezithile zenhliziyo, izifo zamaphaphu, noma izinkinga zezinso kungenzeka bangabi ngabazongenela kahle, njengoba lezi zitho zidinga ukusebenza kahle ukuze zibhekane nokucindezeleka kokwelashwa. Udokotela wakho uzoqhuba ukuhlolwa okubanzi, okuhlanganisa ukuhlolwa komsebenzi wenhliziyo nezifundo zomsebenzi wamaphaphu, ukuze aqinisekise ukuthi unempilo ngokwanele ukuze wenze le nqubo.

Uma unomlando wezifo eziqatha zokuzivikela komzimba, le mithi kungenzeka ingakulungele. Njengoba i-CAR-T therapy inika amandla uhlelo lwakho lomzimba lokuzivikela, kungenzeka lenze izimo zokuzivikela komzimba zibe zimbi lapho uhlelo lwakho lomzimba lokuzivikela seluvele lusebenza ngokweqile.

Abesifazane abakhulelwe noma abancelisa ngamabele akufanele bathole le mithi, njengoba imiphumela ezinganeni ezisakhulayo ingaziwa. Ngaphezu kwalokho, kokubili amadoda nabesifazane kufanele basebenzise izindlela zokuvimbela inzalo eziphumelelayo ngesikhathi sokwelashwa kanye nesikhathi esithile ngemva kwalokho.

Idecabtagene Vicleucel Brand Name

Idecabtagene vicleucel ithengiswa ngaphansi kwegama lomkhiqizo elithi Abecma. Leli gama lomkhiqizo yilokho ozovame ukukubona emaphepheni esibhedlela nasemadokhumenti omshwalense, nakuba ithimba lakho lezokwelapha lingase libhekisele kulo ngamagama amaningi.

Ungase futhi uzwe kubizwa ngokuthi

I-Abecma yenziwa yi-Bristol Myers Squibb ngokubambisana ne-bluebird bio. Kubalulekile ukuqaphela ukuthi lokhu kuyindlela yokwelapha ekhethekile kakhulu etholakala kuphela ezikhungweni zezokwelapha eziqinisekisiwe ezinobuchwepheshe obuthile ekwelapheni ngamaseli e-CAR-T.

Ezinye izindlela zokwelapha i-Idecabtagene Vicleucel

Uma i-idecabtagene vicleucel ingakulungele, noma uma uhlola zonke izinketho zakho, kunezindlela eziningana zokwelapha ezinye ze-multiple myeloma eziphindelelayo. Udokotela wakho uzokusiza ukuthi uqonde ukuthi yiziphi ezingase zifaneleke kakhulu esimweni sakho esithile.

I-Ciltacabtagene autoleucel (Carvykti) enye indlela yokwelapha ngamaseli e-CAR-T eqondise iphrotheni efanayo ye-BCMA kodwa isebenzisa indlela ehlukile kancane. Iphinde yamukelwe ezigulini ze-multiple myeloma eziye zazama ukwelashwa okuningi kwangaphambilini, futhi ezinye izifundo zikhomba ukuthi ingasebenza ngisho nasezigulini ebezithole ezinye izindlela zokwelapha ze-CAR-T.

Ama-bispecific T-cell engagers amelela enye indlela entsha. Lokhu kufaka phakathi imithi efana ne-teclistamab (Tecvayli) ne-elranatamab (Elrexfio), esiza ukuxhuma amaseli akho e-T ngqo kumangqamuzana omdlavuza ngaphandle kokudinga ukuguqulwa kwezakhi zofuzo. Lezi zindlela zokwelapha zinikezwa ngemijovo futhi zingaphathwa ezindaweni ezingaphandle.

Izindlela zokwelapha ezijwayelekile zokuhlanganisa zihlala ziyizinketho ezibalulekile futhi. Lokhu kungase kufake phakathi ukuhlanganiswa okusha kwemithi ye-immunomodulatory, izithiyo ze-proteasome, nama-monoclonal antibodies angazange abe yingxenye yezindlela zakho zokwelapha zangaphambilini.

Kwezinye iziguli, ukufakelwa kwamangqamuzana esiqu okwesibili kungase kucatshangelwe, ikakhulukazi uma ube nokuphendula okuhle ekufakweni kwakho kokuqala futhi sekudlule iminyaka eminingana kusukela kulokho kwelashwa. Izivivinyo zemitholampilo eziphenya izindlela ezintsha ngokuphelele nazo zitholakala njalo futhi zingase zinikeze ukufinyelela ekwelashweni okusha.

Ingabe i-Idecabtagene Vicleucel ingcono kune-Ciltacabtagene Autoleucel?

Kokubili i-idecabtagene vicleucel (Abecma) kanye ne-ciltacabtagene autoleucel (Carvykti) kuyizindlela ezinhle zokwelapha ngamaseli e-CAR-T e-multiple myeloma, kodwa zinezinye izinto ezingase zenze enye ifaneleke kakhulu esimweni sakho esithile kunenye.

I-Ciltacabtagene autoleucel isebenzisa ukwakheka okuhlukile kwe-CAR okuqondiswe ezingxenyeni ezimbili zephrotheni ye-BCMA esikhundleni esisodwa, okungenzeka ukuthi kuyenza isebenze kahle ekuboneni nasekulweni namaseli omdlavuza. Ezinye izivivinyo zomtholampilo zikhomba ukuthi ingase ikhiqize izimpendulo ezijule kakhulu nezihlala isikhathi eside ezigulini ezithile.

Nokho, i-idecabtagene vicleucel isitholakala isikhathi eside futhi inokuhlangenwe nakho okuningi emhlabeni wangempela ngemuva kwayo. Lokhu kusho ukuthi odokotela banemininingwane eminingi mayelana nemiphumela yesikhathi eside futhi banolwazi oluningi ekuphatheni imiphumela emibi yayo. Inqubo yokukhiqiza ye-ide-cel nayo isungulwe kahle, okungasho izikhathi zokulinda ezimfushane ngezinye izikhathi.

Amaphrofayili emiphumela emibi afana kakhulu phakathi kokwelashwa okubili, nakuba ezinye izifundo zikhomba umehluko omncane emazingeni ezinkingeni ezithile. Ithimba lakho lezokwelapha lizocabangela izinto ezinjengokwelashwa kwakho kwangaphambilini, isimo sakho sempilo yamanje, nokuthi udinga ngokushesha kangakanani ukuqala ukwelashwa lapho likusiza ukuthi ukhethe phakathi kwazo.

Esikhundleni sokuthi eyodwa ibe

Udokotela wakho wezinhliziyo kanye nodokotela wezifo zomdlavuza bazosebenzisana ukuze bahlole ukusebenza kwenhliziyo yakho ngaphambi kokwelashwa. Lokhu ngokuvamile kufaka phakathi i-echocardiogram noma i-MUGA scan ukuze kulinganiswe ukuthi inhliziyo yakho iphampa kahle kangakanani igazi. Uma ukusebenza kwenhliziyo yakho kulimala kakhulu, ithimba lakho lezokwelapha lingase lincomende ukuthuthukisa impilo yenhliziyo yakho kuqala noma ukucabangela ezinye izindlela zokwelapha.

Ngesikhathi sokwelashwa, uzothola ukuqapha okwengeziwe ngezinkinga ezihlobene nenhliziyo. Izindaba ezinhle ukuthi imiphumela eminingi engemihle ehlobene nenhliziyo evela ekwelashweni kwe-CAR-T ingeyesikhashana futhi ilawuleka uma itholwe kusenesikhathi. Ithimba lakho lezokwelapha linolwazi oluningi lokunakekela iziguli ezinemibandela ehlukahlukene yenhliziyo ezithola lokhu kwelashwa.

Kufanele ngenzeni uma ngisebenzisa i-Idecabtagene Vicleucel eningi ngengozi?

Lesi simo asinakwenzeka ukuthi senzeke ngoba i-idecabtagene vicleucel inikezwa kuphela ezikhungweni zezokwelapha ezikhethekile ngabasebenzi abaqeqeshiwe. Umthamo ubalwa ngokunembile ngokuya ngesisindo somzimba wakho kanye nenani lamaseli e-CAR-T akhiqizwe ngqo ngawe.

Ngokungafani nemithi ongase uyithathe ekhaya, lokhu kwelashwa kunikezwa ngenqubo yokufaka amanzi elawulwa ngokucophelela. Kukhona izivivinyo eziningi zokuphepha ukuze kuqinisekiswe ukuthi uthola inani eliqondile. Ithimba lakho lezokwelapha liqinisekisa ubunikazi bakho kanye nomthamo ofanele izikhathi eziningi ngaphambi nangemva kokufakwa kwamanzi.

Uma unokukhathazeka mayelana nokwelashwa kwakho noma uhlangabezana nezimpawu ezingalindelekile ngemva kokuthola ukwelashwa kwe-CAR-T, xhumana nethimba lakho lezokwelapha ngokushesha. Bayatholakala 24/7 ukuze baphendule noma yimiphi imibuzo noma ukukhathazeka ongase ube nakho ngesikhathi sokwelashwa kwakho kanye nesikhathi sokululama.

Kufanele ngenzeni uma ngiphuthelwa umthamo we-Idecabtagene Vicleucel?

I-Idecabtagene vicleucel ngokuvamile inikezwa njengokufakwa okukodwa, ngakho ukuphuthelwa umthamo ngomqondo wendabuko akusebenzi. Kodwa-ke, zikhona izingxenye zenqubo yokwelashwa lapho isikhathi sibalulekile, njenge-chemotherapy yokulungiselela noma usuku oluhleliwe lokufakwa kwamanzi.

Uma ungakwazi ukuthola i-chemotherapy yakho yokulungiselela njengoba kuhlelelwe, ithimba lakho lezokwelapha lizosebenza nawe ukuze lilihlele kabusha ngendlela efanele. Isikhathi phakathi kwe-chemotherapy yokulungiselela kanye nokufakwa kwe-CAR-T cell kuhlelwe ngokucophelela ukuze kuthuthukiswe ukusebenza kahle kokwelashwa.

Uma udinga ukulibazisa ukufakwa kwakho kwe-CAR-T cell nganoma yisiphi isizathu, lokhu kulawuleka. Amaseli akho aqondene nawe angagcinwa ngokuphepha isikhathi esithile ngenkathi ubhekana nanoma yiziphi izinkinga zezempilo noma ezinye izinto ezingase zivele. Ithimba lakho lezokwelapha lizoxhumanisa isikhathi esisha ukuze liqinisekise umphumela ongcono kakhulu.

Ngingayeka nini Ukuthatha Idecabtagene Vicleucel?

Njengoba i-idecabtagene vicleucel inikezwa njengokwelashwa okukodwa kunokwelashwa okuqhubekayo, akukho ndawo yokuthatha isinqumo lapho

Uma i-multiple myeloma yakho ibuyela emva kokuphendula ekuqaleni emthini we-CAR-T, ithimba lakho lezokwelapha lizohlola izinto eziningana ukuze linqume izinyathelo ezilandelayo ezingcono kakhulu. Lokhu kungabandakanya ezinye izindlela zokwelapha ze-CAR-T, ama-antibody e-bispecific, izinhlanganisela zokwelapha ngamakhemikhali zendabuko, noma izivivinyo zemitholampilo eziphenya ngezindlela ezintsha.

Ezinye iziguli ezigula ngalesi sifo emva kokwelashwa nge-CAR-T zingaba ngabazongenela uhlobo oluhlukile lokwelashwa nge-CAR-T, njenge-ciltacabtagene autoleucel, ikakhulukazi uma zibe nokuphendula okuhle ekuqaleni. Ithimba lakho lezokwelapha lizocabangela impilo yakho yonke, ukuthi umuthi wokuqala usebenze isikhathi esingakanani, nokuthi yiziphi ezinye izinketho ezitholakalayo lapho lihlela izinyathelo zakho ezilandelayo.